(Q44221301)

1 December 2017

Bmi-1 promotes the chemoresistance, invasion and tumorigenesis of pancreatic cancer cells (English)

1 reference

1 December 2017

1 reference

Tao Yin

1

1 reference

1 December 2017

Hongji Wei

2

1 reference

1 December 2017

Zhenwei Leng

3

1 reference

1 December 2017

Zhiyong Yang

4

1 reference

1 December 2017

Shanmiao Gou

5

1 reference

1 December 2017

Heshui Wu

6

1 reference

1 December 2017

Gang Zhao

7

1 reference

1 December 2017

Xiaoqing Hu

8

1 reference

1 December 2017

Chunyou Wang

9

1 reference

1 December 2017

1 January 2011

1 reference

1 December 2017

1 reference

1 December 2017

57

1 reference

1 December 2017

6

1 reference

1 December 2017

488-496

1 reference

Pancreatic cancer: pathogenesis, prevention and treatment

1 December 2017

1 reference

21 January 2018

Cancer statistics, 2006

1 reference

The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer

21 January 2018

1 reference

Cancer stem cells in solid tumors.

21 January 2018

1 reference

Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications

21 January 2018

1 reference

Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells

21 January 2018

1 reference

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis

21 January 2018

1 reference

Bmi-1, stem cells and cancer

21 January 2018

1 reference

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

21 January 2018

1 reference

Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma.

21 January 2018

1 reference

Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer

21 January 2018

1 reference

Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells

21 January 2018

1 reference

21 January 2018

1 reference

Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway

21 January 2018

1 reference

Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer

21 January 2018

1 reference

Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins

21 January 2018

1 reference

Establishment of clonal colony-forming assay for propagation of pancreatic cancer cells with stem cell properties

21 January 2018

1 reference

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

Development and characterization of gemcitabine-resistant pancreatic tumor cells.

21 January 2018

1 reference

Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways.

21 January 2018

1 reference

Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis

21 January 2018

1 reference

Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death

21 January 2018

1 reference

Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids

21 January 2018

1 reference

Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition

21 January 2018

1 reference

Bmi1 regulates mitochondrial function and the DNA damage response pathway

21 January 2018

1 reference

The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells

21 January 2018

1 reference

Pancreatic cancer biology and genetics

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000334103

1 reference

1 December 2017

1 reference